Verralize
PrivateCompany Overview
Verralize is a biotechnology company that provides an electrochemical biosensor platform for precision testing and diagnostics solutions for on-site, real-time detection of contaminants and pathogens.
Sector
Healthcare & Life Sciences
Verticals
Environmental Monitoring, Biotechnology, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Verralize Comparables
Compare Verralize with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FREDsense Technologies Corp. | 84% | |
| Regabio | 77% | |
| LuminUltra | 72% | |
Verralize Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2024
Grew 28% QoQ, from 18 to 23 employees.
- Sep 15, 2024
Grew 29% QoQ, from 17 to 22 employees.
Verralize Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Verralize's valuation, stock price, and market status.